# Abercrombie & Fitch Co: financial statements, quarterly

ANF · NYSE · CIK 1018840 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/anf.md) · [Financials](/companies/anf/financials.md) · [Filings](/companies/anf/filings.md) · [Insiders](/companies/anf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/anf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,056](/filings/0001018840-24-000087.md) | [1,453 d](/filings/0001018840-26-000012.md) | [1,021](/filings/0001018840-25-000033.md) | [1,134](/filings/0001018840-25-000045.md) | [1,209](/filings/0001018840-25-000048.md) | [1,585 d](/filings/0001018840-26-000012.md) | [1,097](/filings/0001018840-26-000036.md) | [1,209](/filings/0001018840-26-000047.md) | [1,291](/filings/0001018840-25-000048.md) | [1,670 d](/filings/0001018840-26-000012.md) | [1,114](/filings/0001018840-26-000036.md) | [1,267](/filings/0001018840-26-000047.md) |
| Cost of revenue | $m | [371](/filings/0001018840-24-000087.md) | not reported | [343](/filings/0001018840-25-000033.md) | [398](/filings/0001018840-25-000045.md) | [422](/filings/0001018840-25-000048.md) | not reported | [417](/filings/0001018840-26-000036.md) | [452](/filings/0001018840-26-000047.md) | [484](/filings/0001018840-25-000048.md) | not reported | [414](/filings/0001018840-26-000036.md) | [366](/filings/0001018840-26-000047.md) |
| Gross profit | $m | [686](/filings/0001018840-24-000087.md) | [914 d](/filings/0001018840-24-000019.md) | [677](/filings/0001018840-24-000041.md) | [736](/filings/0001018840-24-000071.md) | [787](/filings/0001018840-24-000087.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [138](/filings/0001018840-24-000087.md) | [223 d](/filings/0001018840-26-000012.md) | [130](/filings/0001018840-25-000033.md) | [176](/filings/0001018840-25-000045.md) | [179](/filings/0001018840-25-000048.md) | [256 d](/filings/0001018840-26-000012.md) | [102](/filings/0001018840-26-000036.md) | [207](/filings/0001018840-26-000047.md) | [155](/filings/0001018840-25-000048.md) | [236 d](/filings/0001018840-26-000012.md) | [88.8](/filings/0001018840-26-000036.md) | [253](/filings/0001018840-26-000047.md) |
| Interest expense | $m | not reported | not reported | [5.8](/filings/0001018840-24-000041.md) | [5.2](/filings/0001018840-24-000071.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [39.6](/filings/0001018840-24-000087.md) | [66.5 d](/filings/0001018840-26-000012.md) | [19.8](/filings/0001018840-25-000033.md) | [45.4](/filings/0001018840-25-000045.md) | [54.2](/filings/0001018840-25-000048.md) | [75.3 d](/filings/0001018840-26-000012.md) | [26.6](/filings/0001018840-26-000036.md) | [65.7](/filings/0001018840-26-000047.md) | [45.9](/filings/0001018840-25-000048.md) | [67.6 d](/filings/0001018840-26-000012.md) | [26.0](/filings/0001018840-26-000036.md) | [74.8](/filings/0001018840-26-000047.md) |
| Net income | $m | [96.2](/filings/0001018840-24-000087.md) | [158 d](/filings/0001018840-26-000012.md) | [114](/filings/0001018840-25-000033.md) | [133](/filings/0001018840-25-000045.md) | [132](/filings/0001018840-25-000048.md) | [187 d](/filings/0001018840-26-000012.md) | [80.4](/filings/0001018840-26-000036.md) | [141](/filings/0001018840-26-000047.md) | [113](/filings/0001018840-25-000048.md) | [172 d](/filings/0001018840-26-000012.md) | [67.1](/filings/0001018840-26-000036.md) | [184](/filings/0001018840-26-000047.md) |
| Diluted EPS | $ per share | [1.83](/filings/0001018840-24-000087.md) | not reported | [2.14](/filings/0001018840-25-000033.md) | [2.50](/filings/0001018840-25-000045.md) | [2.50](/filings/0001018840-25-000048.md) | not reported | [1.59](/filings/0001018840-26-000036.md) | [2.91](/filings/0001018840-26-000047.md) | [2.36](/filings/0001018840-25-000048.md) | not reported | [1.47](/filings/0001018840-26-000036.md) | [4.17](/filings/0001018840-26-000047.md) |
| Basic EPS | $ per share | [1.91](/filings/0001018840-24-000087.md) | not reported | [2.24](/filings/0001018840-25-000033.md) | [2.60](/filings/0001018840-25-000045.md) | [2.59](/filings/0001018840-25-000048.md) | not reported | [1.63](/filings/0001018840-26-000036.md) | [2.97](/filings/0001018840-26-000047.md) | [2.41](/filings/0001018840-25-000048.md) | not reported | [1.49](/filings/0001018840-26-000036.md) | [4.20](/filings/0001018840-26-000047.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [649](/filings/0001018840-24-000087.md) | [901](/filings/0001018840-26-000012.md) | [864](/filings/0001018840-25-000033.md) | [738](/filings/0001018840-25-000045.md) | [683](/filings/0001018840-25-000048.md) | [773](/filings/0001018840-26-000047.md) | [511](/filings/0001018840-26-000036.md) | [573](/filings/0001018840-26-000047.md) | [606](/filings/0001018840-25-000048.md) | [760](/filings/0001018840-26-000047.md) | [594](/filings/0001018840-26-000036.md) | [628](/filings/0001018840-26-000047.md) |
| Current assets | $m | [1,441](/filings/0001018840-23-000091.md) | [1,537](/filings/0001018840-25-000013.md) | [1,510](/filings/0001018840-24-000041.md) | [1,517](/filings/0001018840-24-000071.md) | [1,656](/filings/0001018840-24-000087.md) | [1,673](/filings/0001018840-26-000012.md) | [1,374](/filings/0001018840-25-000033.md) | [1,489](/filings/0001018840-25-000045.md) | [1,610](/filings/0001018840-25-000048.md) | [1,650](/filings/0001018840-26-000047.md) | [1,415](/filings/0001018840-26-000036.md) | [1,546](/filings/0001018840-26-000047.md) |
| Total assets | $m | [2,898](/filings/0001018840-23-000091.md) | [2,974](/filings/0001018840-26-000012.md) | [2,970](/filings/0001018840-25-000033.md) | [3,050](/filings/0001018840-25-000045.md) | [3,270](/filings/0001018840-25-000048.md) | [3,300](/filings/0001018840-26-000012.md) | [3,096](/filings/0001018840-26-000036.md) | [3,302](/filings/0001018840-26-000047.md) | [3,480](/filings/0001018840-25-000048.md) | [3,542](/filings/0001018840-26-000047.md) | [3,453](/filings/0001018840-26-000036.md) | [3,595](/filings/0001018840-26-000047.md) |
| Current liabilities | $m | [1,027](/filings/0001018840-23-000091.md) | [967](/filings/0001018840-25-000013.md) | [920](/filings/0001018840-24-000041.md) | [1,052](/filings/0001018840-24-000071.md) | [1,182](/filings/0001018840-24-000087.md) | [1,127](/filings/0001018840-26-000012.md) | [999](/filings/0001018840-25-000033.md) | [1,038](/filings/0001018840-25-000045.md) | [1,163](/filings/0001018840-25-000048.md) | [1,106](/filings/0001018840-26-000047.md) | [977](/filings/0001018840-26-000036.md) | [1,099](/filings/0001018840-26-000047.md) |
| Long-term debt | $m | [248](/filings/0001018840-23-000091.md) | [222](/filings/0001018840-25-000013.md) | [213](/filings/0001018840-24-000041.md) | [0.0](/filings/0001018840-24-000071.md) | [0.0](/filings/0001018840-24-000087.md) | [0.0](/filings/0001018840-25-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [866](/filings/0001018840-23-000091.md) | [1,035](/filings/0001018840-25-000013.md) | [1,079](/filings/0001018840-24-000041.md) | [1,207](/filings/0001018840-24-000071.md) | [1,247](/filings/0001018840-24-000087.md) | [1,336](/filings/0001018840-26-000012.md) | [1,189](/filings/0001018840-25-000033.md) | [1,292](/filings/0001018840-25-000045.md) | [1,317](/filings/0001018840-25-000048.md) | [1,404](/filings/0001018840-26-000047.md) | [1,340](/filings/0001018840-26-000036.md) | [1,355](/filings/0001018840-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [134 d](/filings/0001018840-24-000087.md) | [303 d](/filings/0001018840-26-000012.md) | [95.0](/filings/0001018840-25-000033.md) | [165 d](/filings/0001018840-25-000045.md) | [143 d](/filings/0001018840-25-000048.md) | [308 d](/filings/0001018840-26-000012.md) | [(4.0)](/filings/0001018840-26-000036.md) | [117 d](/filings/0001018840-26-000047.md) | [200 d](/filings/0001018840-25-000048.md) | [306 d](/filings/0001018840-26-000012.md) | [44.3](/filings/0001018840-26-000036.md) | [269 d](/filings/0001018840-26-000047.md) |
| Capital expenditure | $m | [38.8 d](/filings/0001018840-24-000087.md) | [29.2 d](/filings/0001018840-26-000012.md) | [38.9](/filings/0001018840-25-000033.md) | [42.8 d](/filings/0001018840-25-000045.md) | [50.4 d](/filings/0001018840-25-000048.md) | [50.9 d](/filings/0001018840-26-000012.md) | [50.8](/filings/0001018840-26-000036.md) | [66.2 d](/filings/0001018840-26-000047.md) | [68.3 d](/filings/0001018840-25-000048.md) | [55.6 d](/filings/0001018840-26-000012.md) | [61.3](/filings/0001018840-26-000036.md) | [68.0 d](/filings/0001018840-26-000047.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001018840-24-000087.md) | [0.0 d](/filings/0001018840-26-000012.md) | [15.0](/filings/0001018840-25-000033.md) | [15.0 d](/filings/0001018840-25-000045.md) | [99.8 d](/filings/0001018840-25-000048.md) | [100 d](/filings/0001018840-26-000012.md) | [200](/filings/0001018840-26-000036.md) | [51.2 d](/filings/0001018840-26-000047.md) | [100 d](/filings/0001018840-25-000048.md) | [100 d](/filings/0001018840-26-000012.md) | [105](/filings/0001018840-26-000036.md) | [181 d](/filings/0001018840-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.5](/filings/0001018840-23-000091.md) | [51.5](/filings/0001018840-24-000041.md) | [51.5](/filings/0001018840-24-000071.md) | [52.6](/filings/0001018840-24-000087.md) | [53.3](/filings/0001018840-25-000033.md) | [53.3](/filings/0001018840-25-000045.md) | [52.9](/filings/0001018840-25-000048.md) | [50.6](/filings/0001018840-26-000036.md) | [48.6](/filings/0001018840-26-000047.md) | [47.9](/filings/0001018840-25-000048.md) | [45.7](/filings/0001018840-26-000036.md) | [44.1](/filings/0001018840-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,434,377 at 2026-08-28, from the cover of the [10-Q filed 2026-09-04](/filings/0001018840-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.